Soluble Receptor Activator of Nuclear Factor-κB Ligand (RANKL) as a Novel Serum Marker of Disease Progression and Bone Destruction in Juvenile Rheumatoid Arthritis
Mohamed Mahmoud Abdel-Razek;
Abstract
RANKL is a type II transmembrane protein cytokine of the TNF-superfamily and is a key player in bone metabolism. It plays a critical role in the regulation of osteoclastogenesis and regulation of osteogenic disorders such as osteoporosis and JRA. T
Other data
| Title | Soluble Receptor Activator of Nuclear Factor-κB Ligand (RANKL) as a Novel Serum Marker of Disease Progression and Bone Destruction in Juvenile Rheumatoid Arthritis | Authors | Mohamed Mahmoud Abdel-Razek | Keywords | Soluble Receptor Activator of Nuclear Factor-κB Ligand (RANKL) as a Novel Serum Marker of Disease Progression and Bone Destruction in Juvenile Rheumatoid Arthritis | Issue Date | 2007 | Description | RANKL is a type II transmembrane protein cytokine of the TNF-superfamily and is a key player in bone metabolism. It plays a critical role in the regulation of osteoclastogenesis and regulation of osteogenic disorders such as osteoporosis and JRA. T |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.